# Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

> **NCT00348686** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 315 (actual)

## Conditions studied

- Hypertension
- Left Ventricular Hypertrophy

## Interventions

- **DRUG:** Candesartan
- **DRUG:** Candesartan
- **DRUG:** Felodipine
- **DRUG:** Felodipine

## Key facts

- **NCT ID:** NCT00348686
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 315 (ACTUAL)
- **Last updated:** 2012-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348686, "Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00348686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*